Suppr超能文献

使用HYDE评分法评估非核苷类抑制剂与HIV-1逆转录酶的结合情况。

Assessment of Nonnucleoside Inhibitors Binding to HIV-1 Reverse Transcriptase Using HYDE Scoring.

作者信息

Paneth Agata, Płonka Wojciech, Paneth Piotr

机构信息

Faculty of Pharmacy with Medical Analytics Division, Medical University of Lublin, Chodźki 4a, 20-093, Lublin, Poland.

FQS-Fujitsu Poland, Parkowa 11, 33-332 Kraków, Poland.

出版信息

Pharmaceuticals (Basel). 2019 Apr 24;12(2):64. doi: 10.3390/ph12020064.

Abstract

In this study, 48 inhibitors were docked to 107 allosteric centers of human immunodeficiency virus 1 (HIV-1) reverse transcriptase from the Protein Data Bank (PDB). Based on the average binding scores, quantitative structure-activity relationship (QSAR) equations were constructed in order to elucidate directions of further development in the design of inhibitors. Such developments, informed by structural data, must have a focus on activity against mutated forms of the enzyme, which are the cause of the emergence of multidrug-resistant viral strains. Docking studies employed the HYDE scoring function. Two types of QSARs have been considered: One based on topological descriptors and the other on structural fragments of the inhibitors. Both methods gave similar results, indicating substructures favoring binding to mutated forms of the enzyme.

摘要

在本研究中,从蛋白质数据库(PDB)获取了48种抑制剂,并将其与人类免疫缺陷病毒1(HIV-1)逆转录酶的107个变构中心进行对接。基于平均结合分数,构建了定量构效关系(QSAR)方程,以阐明抑制剂设计的进一步发展方向。这种基于结构数据的发展,必须专注于针对该酶突变形式的活性,而这些突变形式是多药耐药病毒株出现的原因。对接研究采用了HYDE评分函数。考虑了两种类型的QSAR:一种基于拓扑描述符,另一种基于抑制剂的结构片段。两种方法都得到了相似的结果,表明存在有利于与该酶突变形式结合的亚结构。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aba8/6631718/c2748275ab40/pharmaceuticals-12-00064-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验